A Data Analysis of the Predictive Risks for Readmission of Patients with Depression Post-Myocardial Infarction by Dobberstein, Katlyn Anne
A DATA ANALYSIS OF THE PREDICTIVE RISKS FOR READMISSION OF PATIENTS 
WITH DEPRESSION POST-MYOCARDIAL INFARCTION 
A Dissertation 
Submitted to the Graduate Faculty 
of the 
North Dakota State University 
of Agriculture and Applied Science 
By 
Katlyn Anne Dobberstein 
In Partial Fulfillment of the Requirements 
for the Degree of 
DOCTOR OF NURSING PRACTICE 
Major Department: 
Nursing 
 
 
 
 
March 2018 
Fargo, North Dakota 
  
North Dakota State University 
Graduate School 
 
Title 
 A DATA ANALYSIS OF THE PREDICTIVE RISKS FOR 
READMISSION OF PATIENTS WITH DEPRESSION  
POST-MYOCARDIAL INFARCTION 
  
  
  By   
  
Katlyn Anne Dobberstein 
  
     
    
  The Supervisory Committee certifies that this disquisition complies with North Dakota 
State University’s regulations and meets the accepted standards for the degree of 
 
  DOCTOR OF NURSING PRACTICE  
    
    
  SUPERVISORY COMMITTEE:  
    
  
Dr. Dean Gross 
 
  Chair  
  
Dr. Mykell Barnacle 
 
  
Dr. Daniel Friesner 
 
  
 
 
    
    
  Approved:  
   
 03/26/2018   Dr. Carla Gross   
 Date  Department Chair  
    
 iii 
ABSTRACT 
Depression is prevalent in patients with cardiovascular disease (CVD). Past studies have 
found that one in five patients experience depression post-myocardial infarction (MI) (Osler et 
al., 2016; Thombs et al., 2006). Patients with depression post-MI are at increased risk for adverse 
outcomes, mortality, and readmission to the hospital (Hess et al., 2016; Szpakowski, Bennell, 
Qui, Kirdyak, & Wijeysundera, 2016). This study utilized retrospective data obtained from 
electronic medical records (EMRs) to examine the relationship between readmission rates and 
depression post-MI. The sample consisted of 593 patients with depression post-MI, and 98 
patients, or 16.5%, were readmitted within 12 months post-MI. Demographic data including age, 
gender, and race were also analyzed in the study. The ICD-9 and ICD-10 codes requested 
consisted of MI and depression codes to ensure inclusion of all types of MI and depression 
diagnoses. The data sample consisted of men and women ages 40-70 years old who had a 
diagnosis of depression, had experienced an MI, and had visited their primary care provider 
within 12 months post-MI. The data were gathered from a date range of January 1st, 2012 to 
December 31st, 2016 to include a five-year representation of data. Using a Chi-Square Test of 
Independence and a Fischer’s Exact Test, the findings of the data analysis concluded that there 
was no significant relationship (Region 1 P-value=0.6921; Region 2 P-value=0.4613) between 
depression screening and readmission in post-myocardial infarction patients for both regions 
examined within the organization. However, treatment data was not obtainable for the data sets, 
therefore, an analysis of the relationship between depression treatment and readmissions post-MI 
was not possible. Despite these findings, current guidelines and past evidence continue to 
recommend depression screening in post-MI patients to ensure patients receive appropriate 
treatment and care. Overall, recommendations of this study are for future studies to examine 
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depression screening, include analysis of treatment in post-MI patients, and for practitioners to 
screen post-MI patients for depression per the guidelines. 
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CHAPTER ONE: INTRODUCTION 
The connection between the body and mind continues to be a growing topic in research 
and clinical practice. Depression is the leading cause of disability world-wide, and 
cardiovascular disease (CVD) continues to be the deadliest disease world-wide and in the United 
States (Friederich, 2017; Mozzafarian et al., 2015; National Center for Health Statistics, 2017). 
The economic burden of depression is estimated at $210.5 billion, and the most significant 
portion of this burden relates to comorbidities with depression (Greenberg, Fournier, Sisitsky, 
Pike, & Kessler, 2015). Depression is most common in the first 12 months following a 
myocardial infarction (MI), and occurs in 45% of patients with a peak occurrence at 3 months 
post-MI (Haws, Ramjeet, & Gray, 2011). However, depression often goes unrecognized in 
patients with cardiovascular disease (CVD), thus creating an area of concern.  
In chapter one, the background and significance of depression in post-MI patients will be 
discussed. Current screening recommendations, prevalence of depression post-MI, and 
readmission in this cohort will be outlined to further demonstrate the importance of screening 
and treating depressed post-MI patients. Once the background has been examined, the 
significance of the project in relation to nursing and the healthcare organization is discussed. The 
purpose of this project, identifying predictive risks for readmission in depressed post-MI 
patients, will be examined along with the project objectives. 
Background and Significance 
The prevalence of depression in patients with CVD is significant, and subsequently the 
American Heart Association (AHA) has developed recommendations that routine screening for 
depression in patients with CVD be performed (Lichtman et al., 2008). The American Academy 
of Family Physicians (AAFP) went one step further and recommended depression screening in 
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patients specifically post-MI. Their recommendations are to screen for depression in patients 
who have had a myocardial infarction at regular intervals throughout the post-MI period (Green 
et al., 2009). Despite these recommendations, screening for depression post-MI is often missed.  
A study examining prevalence of depression post-MI found that almost 19% of post-MI 
patients had depression 3 months post-MI, and only 3.3% of these patients were screened for 
depression in the first 3 months post-MI (Larsen, 2013). This compares to the prevalence of 
depression in the general population of 6.7% (Center for Behavioral Health Statistics and 
Quality, 2016). Ziegelstein et al. (2005) examined the ability of healthcare workers to identify 
depression in post-MI patients without use of a formal screen, and found that without a formal 
screen there was up to a 75% false-negative rate in recognizing depressive symptoms. The 
authors recommend that formal screening be incorporated into routine post-MI care (Ziegelstein 
et al., 2005). A similar study by Huffman et al. (2006) estimated that <15% of depressed CVD 
patients are diagnosed and treated for their depression. Therefore, the high prevalence of 
depression and under-recognition of depressive symptoms in cardiac patients is concerning. 
Readmission to the hospital is a significant burden in healthcare. A study by Pederson, 
Warkentin, Majumdar, and McAlister (2016) found that patients who suffered from depression 
after discharge from the hospital had a 73% increased risk for readmission, and two-fold risk for 
death in 30 days compared to patients without depression. A study examining readmission 
specifically in patients post-MI, found that 61.7% of 3,609 patients were re-hospitalized within 
one year post-discharge (Southern et al., 2014). Beginning in 2012, the Centers for Medicare & 
Medicaid Services (CMS) were required by the Affordable Care Act to reduce reimbursement to 
healthcare organizations with excessive hospital readmissions for certain diagnoses, including 
MI’s, and measures early readmission within 30 days post-discharge (Centers for Medicare & 
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Medicaid Services, 2016). The literature suggests that depression screening and treatment will 
lead to less readmissions post-MI, decreased emergency room visits, and overall cost savings for 
patients and healthcare organizations (Celano et al., 2016; Huffman et al., 2014). 
Unfortunately, readmission for post-MI patients is high, as studies have found a 20% 
readmission rate in post-MI patients within 30-days post-discharge (Dharmarajan et al., 2013; 
Southern et al., 2014). Patients with a psychiatric comorbidity, such as depression, have an even 
higher rate of readmission post-MI. A study by Ahmedani et al. (2015) found that there was a 
6% increase in the rate of readmission in depressed post-MI patients compared to post-MI 
patients without depression. Costs for readmission post-MI are substantially high. As part of the 
Healthcare Cost & Utilization Project (HCUP), the Agency for Research and Healthcare Quality 
(AHQR) examined trends of United States hospital readmissions in 2013, and found that there 
were over 71,000 readmissions for MI patients totaling over $1 billion in aggregate hospital costs 
(Fingar & Washington, 2015). 
Statement of the Problem 
In a meeting with the Family Medicine Director of Clinic Operations in Region 1 of the 
midwestern healthcare organization (MHO), the director expressed interest for improved mental 
healthcare in primary care. The director expressed interest in a project examining depression 
screening in cardiac patients with a focus on readmissions. The readmission rates in depressed 
post-MI patients were largely unknown for the MHO, therefore, a data analysis examining 
predictive risks for readmission in depressed post-MI patients was necessary.  
Significance for Nursing and the MHO 
The research conducted in this project has potential implications for improved depression 
healthcare for patients post-MI. Depression is a modifiable risk factor in CVD, thus by 
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identifying and treating depressive symptoms patients will less likely have a cardiac-related 
readmission (Reese et al., 2011). Depression screening will increase the amount of identified 
depression in post-MI patients, and allow for patients to be treated appropriately. With improved 
depression care, the literature suggests patients will have decreased mortality, less adverse 
outcomes, and a reduced risk for readmission to the hospital (Banankhah, Friedmann, & Thomas, 
2015; Myers, Gerber, Benyamini, Goldbourt, & Drory, 2012; Pederson et al., 2016). Thus, 
depression screening and treatment in post-MI patients can potentially result in healthcare cost-
savings for patients and healthcare organizations. 
Project Description 
Project Purpose 
The purpose of this project was to identify predictive risks of readmission in post-MI 
patients within the MHO. The project intended to focus on examination of depression screening 
in relation to readmission of post-MI patients. Also, the project intended to examine readmission 
rates in patients who were screened and treated for depression post-MI. Other data examined 
included demographics, such as age, gender, race, and region to make comparisons to past 
research and identify any correlations. The analysis examined what type of provider was 
screening for depression, and the specialty of the provider performing the screening. By 
identifying potential risks for readmission in post-MI patients with depression, recommendations 
could be made for improved mental health care based on guidelines and past evidence. 
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Project Objectives 
The following objectives were developed for the project: 
1. Determine the percentage of readmission in patients within 12 months post-MI 
who have depression.  
2. Determine the percentage of readmission in patients within 12 months post-MI 
who have depression and were screened for depression. 
3. Determine the percentage of readmission in patients within 12 months post-MI 
who have depression, were screened for depression, and treated for depression. 
4. Identify correlations or differences that can be made for depressed post-MI 
patients and demographic variables. 
5. Determine what type of provider screened, diagnosed, and/or treated for 
depression in the sample. 
These objectives will be discussed with the results in Chapter Four and further evaluated 
in Chapter Five. The use of a Logic Model will be utilized in the development, and in the 
evaluation of the objectives. The Logic Model will be further discussed along with a review of 
the literature, and the theoretical framework for the project within the next chapter. 
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CHAPTER TWO: LITERATURE REVIEW AND THEORETICAL FRAMEWORK 
Introduction 
There is a substantial amount of literature regarding depression and CVD. Relevant and 
current studies were reviewed, and were obtained through multiple searches of the following 
databases: Academic Search Premier, CINAHL Complete, EBSCO MegaFILE, PsychINFO, 
COCHRANE databases of systematic reviews, and PubMed. Key words and search terms 
included but were not limited to: depression, depression screening, primary care, cardiovascular 
disease, coronary heart disease, myocardial infarction, acute myocardial infarction, heart attack, 
and readmission. Reviewing the literature focused on the following areas: depression in post-MI 
patients, recommendations for screening post-MI patients, screening tools, barriers to depression 
screening of post-MI patients, and hospital readmission in post-MI patients with depression.  
Examining the literature regarding depression in post-MI patients helped in identifying 
the prevalence of depression, identifying outcomes for patients, and determining how depression 
is currently managed for this cohort. A review of past literature’s recommendations for 
depression screening in post-MI patients clarified when to screen patients, and determined what 
were recommended screening tools. Next, identifying the barriers to screening post-MI patients 
helped to determine areas potentially needing improvements in mental healthcare. Lastly, review 
of the literature regarding readmission in patients post-MI provided an understanding of what 
may increase risks for readmission. Once risks for readmission have been identified, then 
recommendations may be made to decrease the risk for readmission in post-MI patients with 
depression. 
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Depression in Post-MI Patients 
Patients who have experienced an MI are commonly found to have depression. Studies 
have found that one in every five patients hospitalized with an MI had symptoms for major 
depression (Osler et al., 2016; Thombs et al., 2006). Depression post-MI may also be a 
significant prognostic factor with studies indicating a worse prognosis for mortality remaining 
consistent over the past 25 years (Meijer et al., 2011). The AHA recently conducted a systematic 
review of literature examining depression as a risk factor for poor prognosis in patients post-MI. 
The committee recommended that depression be recognized as an established risk factor for poor 
prognosis after an MI due to an increase in risk for all-cause and cardiac mortality post-MI 
(Lichtman et al., 2014).  
Prevalence and Mortality 
Historically, depression in post-MI patients has been prevalent. As stated earlier, a 
systematic review by Thombs et al. (2006) examined the prevalence of depression in over 14,000 
patients, and found that major depression occurred in 1 out of 5 post-MI patients. In a recent 
cohort study by Osler et al. (2016), depression was also found to occur in 20% of the 97,793 
patients examined within 2 years post-MI. This prevalence rate is similar to previous study 
results that also show major depression is present in 20% of post-MI patients (Thombs et al., 
2006). A more recent study examined 25,000 patients after a diagnosis of MI, and found that 
15% of those patients were diagnosed with depression (May et al., 2017). For reference, the 
depression prevalence rate of the general population is 6.7% (Center for Behavioral Health 
Statistics and Quality, 2016). 
Several studies have found an association between post-MI patients who have depression 
and adverse outcomes. A meta-analysis examining 25 years of past research concluded that post-
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MI depression has a 2.25 times increased risk of all-cause mortality, and a 2.71 times increased 
risk of cardiac mortality (Meijer et al., 2011). A study by Osler et al. (2016) had similar results 
and found that depression in post-MI patients is associated with an increased risk of mortality in 
both patients who were previously diagnosed with depression and patients who developed new 
onset depression. A more recent study emphasized that having a previous diagnosis of depression 
will increase all-cause mortality, and concluded that history of depression is an adverse 
prognostic factor for post-MI patients (Sundboll et al., 2017). In fact, depression has been found 
to double the risk of death after an MI and/or diagnosis of CVD (May et al., 2017). Lastly, an 
important finding in the literature is that untreated depression had twice as high of a mortality 
rate compared to treated depression one year post-MI (Smolderen et al., 2017). This last point 
emphasizes the importance of depression treatment in post-MI patients. 
Management of Depression Post-MI 
Multiple studies have examined depression treatment after an MI. Treatment options for 
depression include non-pharmacologic methods and pharmacologic methods. The majority of the 
studies in the literature evaluated cardiac outcomes with use of cognitive behavior therapy and/or 
use of antidepressants, typically with use of a selective serotonin reuptake inhibitor (SSRI). In a 
review by Maverides and Nemeroff (2013), SSRI’s were found to be the safest medication in 
patients with CVD, and recommend sertraline as first-line therapy for this patient population. 
SSRI’s may also decrease risk for an arrhythmia and/or MI (Coupland et al., 2016). The AHA 
recommends sertraline or citalopram as first-line pharmacologic therapy for depression in 
cardiac patients, and that cognitive behavioral therapy and physical activity are effective in 
reducing depressive symptoms (Lichtman et al., 2008). 
 9 
The Enhancing Recovery in Coronary Heart Disease (ENRICHD) trial implemented 
cognitive behavior therapy and SSRI treatment in 2,481 post-MI patients with depression. The 
authors found that the treatment had no impact on survival, however, it did improve patients’ 
depression and social isolation (Berkman et al., 2003). A post-hoc analysis of the ENRICHD 
study found a significant decrease in risk for a recurrent MI and/or death in patients who were on 
a SSRI (Taylor et al., 2005). Another secondary data analysis using the ENRICHD trial data 
examined the effects of adequate treatment for depression post-MI. The analysis concluded that 
treating depression effectively decreased mortality (Banankhah et al., 2015). 
In the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART), the 
authors examined the impact of sertraline treatment in post-MI patients with depression. Results 
of the study found that sertraline is a safe medication for use in patients with depression post-MI, 
and that treatment with sertraline is effective (Glassman et al., 2002). The authors concluded that 
aggressive treatment of depression is indicated post-MI to decrease mortality and increase 
medication adherence in patients (Glassman et al., 2002). 
In looking at the effects of other anti-depressants, a randomized controlled trial 
implemented treatment strategies in depressed post- MI patients examining the effects of 
mirtazapine, citalopram, and psychiatric care. In this study, the authors found that antidepressant 
treatment did not improve cardiovascular outcomes, but treating depression increased survival 
(Zuidersma, Conradi. Van Melle, Ormel, & de Jonge, 2013). The authors surmise that post-MI 
patients who receive antidepressant treatment are more motivated to care for themselves, and 
adhere to new medication and healthy lifestyle recommendations (Zuidersma et al., 2013). 
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Recommendations for Screening 
Depression screening in patients with CVD is supported by multiple organizations. 
Advisories or guidelines have been developed recommending depression screening by the 
following entities: AHA, AAFP, and the National Institute for Health and Care Excellence 
(NICE). The United States Preventative Services Task Force (USPSTF) recently published a 
recommendation statement that depression screening be performed in the general adult 
population, stating that treatment of depression will improve patient outcomes (Siu & USPSTF, 
2016). Overall, each organization has similar recommendations for depression screening. 
The AHA developed their recommendations for screening of depression in response to 
the increased prevalence of depression in CVD patients. The advisory board determined that 
routine screening for depression should be performed in all settings, i.e. primary care, inpatient, 
cardiac rehabilitation, etc. If a patient does screen positive, they must be appropriately evaluated 
in the effort to avoid missing a diagnosis for depression (Lichtman et al., 2008). The AHA 
recommends using a two-step screening process with use of the Patient Health Questionnaire-2 
(PHQ-2). First, using the PHQ-2, and if the screen is positive move onto the PHQ-9 consisting of 
9 questions for a more thorough evaluation (Elderon, Smolderen, Na, & Whooley, 2011).  
The AAFP developed guidelines for detecting depression post-MI that specifically aimed 
for use by the primary care provider. These guidelines were initially developed in 2009, and 
were more recently reaffirmed in 2014 (National Guideline Clearinghouse, 2014). The AAFP 
panel developed their guidelines in response to an evidence report issued by the Agency for 
Healthcare Research and Quality (AHQR). Their screening recommendation is that all patients 
with an MI be screened for depression with a standardized screening tool at regular intervals 
post-MI starting during their hospitalization (Green et al., 2009).  
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European guidelines similarly recommend screening CVD patients for depression, and 
offering treatment if indicated (Perk et al., 2012). The NICE in the United Kingdom, supports 
depression screening in patients with CVD followed by appropriate consult for treatment (NICE, 
2010). The NICE guideline highlights the importance for all patients with depression who screen 
positive to be treated appropriately, and if providers are unsure how to treat that patient they are 
to refer that patient to a mental health specialist (NICE, 2010). The guideline does not 
specifically recommend certain screening intervals or screening tools, but does discuss in-depth 
treatment options for various cases (NICE, 2010). 
Screening Tools for Depression 
Multiple screening tools have been developed for depression, however, there is no single 
screening tool that has been decided upon as a standard for screening. Many screening tools have 
been validated for use in detecting depression. There is no standard depression screening tool for 
cardiac patients that has been identified, however, most researchers have been found to use either 
the PHQ-2, PHQ-9, or Beck’s Depression Inventory (BDI). 
Patient Health Questionnaire Depression Scale 
 The PHQ screening tools are commonly used in multiple healthcare settings with ease of 
use for the provider and patient. The original PHQ is a three page questionnaire that is self-
reported by the patient, and assesses for eight other psychiatric diagnoses including: major 
depression, panic disorder, anxiety disorders, and bulimia nervosa (Kroenke, Spitzer, & 
Williams, 2003). The PHQ-9 was derived from the PHQ to help in diagnosis for major 
depression (Kroenke, Spitzer, & Williams, 2001). The PHQ tools include a two question and/or a 
nine question format. The PHQ-2 and PHQ-9 are recommended by the USPSTF, AHA, and the 
AAFP as depression screening tools (Lichtman, 2008; Mauerer, 2012; Siu & USPSTF, 2016) 
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The PHQ-2 questions the patient regarding frequency of a depressed mood and anhedonia 
over the previous two weeks giving a score of 0 for “not at all” up to a score of 3 for “nearly 
every day”. If a patient screens positive, the PHQ-9 should be conducted. The 2-question format 
allows for a brief, but validated, screening to be given. The PHQ-2 is a condensed screening tool, 
and cannot be used for diagnosis of depression, however, it may be used to rule out depression 
(Mauerer, 2012). The PHQ-2 alone has been proven a valid depression screening tool with 
sensitivity of 86% and specificity of 78% for major depression (Arroll et al., 2010). The short 
form screening tool has specifically been proven a valid tool in CVD patients, and if providers 
are not comfortable using the PHQ-2, then the PHQ-9 is recommended for screening and 
diagnosis in CVD patients (McManus, Pipkin & Whooley, 2005).  
The PHQ-9 is composed of a 9-item tool that is multifunctional, and may be used for 
screening, assisting in making a diagnosis, and/or monitoring of depression symptoms (Mauerer, 
2012). The PHQ-9 is derived from the depression criteria of the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition, (DSM-IV) allowing it to be a screening and diagnostic 
tool if a patient meets the criteria for depression. The PHQ-9 also determines severity of 
depression as no depression, mild depression, moderate depression, moderately severe 
depression, or severe depending on score from 0-27 (Zimmerman, 2012). More specifically a 
score of 0-4 is interpreted as no depression, 5-9 as mild depression, 10-14 moderate depression, 
15-19 as moderately severe, and lastly a score of <19 as severe depression (Kroenke et al., 2001). 
To make a diagnosis for major depression, a patient must have at least 5 out of the 9 depressive 
symptoms criteria for “more than half the days” in the last two weeks and includes either 
depressed mood or anhedonia as one of the symptoms (Kroenke et al., 2003). A meta-analysis of 
the PHQ-9 found that it is a suitable tool for screening and diagnosis of depression, with a 
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diagnostic sensitivity of 92% and specificity of 80% (Gilbody, Richards, Brealey, & Hewitt, 
2007). However, it is recommended to follow-up positive screens with an interview and 
assessment prior to making a diagnosis. The PHQ-9 is also found to work well across different 
cultures, and is easily translated to other languages (Gilbody et al., 2007).  
Beck’s Depression Inventory 
The Beck Depression Inventory (BDI) was initially a 21-item tool assessing different 
symptoms and their severity with a score from 0-3 (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961). The newest version of this tool, the BDI-II, was created after the DSM-IV was released, 
and added four more items from the DSM-IV criteria, including: agitation, worthlessness, 
concentration, and loss of energy (Ceccarini, Manzoni, & Castelnuovo, 2014). The BDI uses 
standardized cut-offs to classify a patient’s score and their severity of depressive symptoms. Use 
of the BDI-II has been found to be an effective screening tool, but not effective in making a 
diagnosis for depression (Ceccarini et al., 2014; Subica et al., 2014). A recent study confirms that 
the BDI-II as a screening tool is adequate and valid for use in the cardiac patient population 
(Moullec, Plourde, Lavoie, Suarthana, & Bacon, 2015). 
Barriers to Depression Screening Post-MI Patients 
Multiple barriers to depression screening of post-MI patients have been found. Often 
screening is not performed due to time constraints in clinical and hospital settings (Smolderen et 
al., 2011). Another common barrier is the lack of mental health resources and referrals available 
once depression has been identified (Davidson, 2012; Smolderen et al., 2011). The opposition by 
professionals against the recommendations for screening is another barrier with claims that there 
is a lack of evidence available to support the recommendations (Thombs et al., 2008). Lastly, a 
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lack of knowledge on depression screening and the treatment that follows has been identified as 
a barrier (Haws et al., 2011). 
Time constraints in performing depression screening is a barrier in both inpatient and 
outpatient settings. A study examining a quality improvement depression screening protocol 
developed by the Mid America Heart and Vascular Institute (MAHVI) found that the time it took 
to screen patients by providers or nurses was a barrier to performing the screen (Smolderen et al., 
2011). Recommendations by the AHA, USPSTF, and the NICE are to make use of short 
depression screening tools to decrease time spent screening, while maintaining effectiveness 
(Lichtman et al., 2008; NICE, 2009; Siu & USPSTF, 2016). 
The shortage of mental health specialists, and the availability for referral has created a 
barrier for some providers to screen their patients for depression. In the study examining the 
MAHVI depression screening protocol, providers reported that the short supply of mental health 
professionals to refer patients to was a barrier for them to screen their CVD patients (Smolderen 
et al., 2011). Again, another examination of barriers in management of depression in patients 
with CVD revealed that primary care providers and cardiologists believe there are inadequate 
mental health specialty referrals available (Davidson, 2012).  
Despite recommendations for routine screening for depression in CVD patients, 
opponents of the recommendations believe the statements were made too early (Hasnain, 
Vieweg, Lesnefsky, & Pandurangi, 2011). Opponents argue that there is a lack of evidence for 
routine screening, that routine screening will result in high-false positive screens, and screening 
may induce a negative social stigma (Thombs et al., 2013; Whooley, 2009). Past clinical trials 
have found that depression screening may improve depressive symptoms, but not necessarily 
affect mortality and morbidity relating to cardiac outcomes (Thombs et al., 2008). An important 
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argument made by opponents to avoid misdiagnosis in a false-positive screen is to ensure a 
clinical interview is conducted prior to diagnosing depression, and that screening be performed 
in a primary care setting with collaborative care resources available (Thombs et al., 2008; 
Whooley, 2009). 
There is a lack of knowledge by providers that depression screening is recommended 
post-MI. A national survey conducted by Haws et al. (2011), examined primary care provider’s 
attitudes and beliefs concerning depression post-MI, finding that providers underestimated the 
prevalence of depression post-MI by 20%. The authors determined that providers failed to 
understand how common depression is in this cohort, and that there was little understanding in 
making a depression diagnosis with help from a screening tool. Providers in the survey preferred 
to use their own experience and clinical knowledge for diagnosis, and results from the survey 
found that 33% of providers do not routinely screen for depression post-MI (Haws et al., 2011). 
Depression Post-MI and Readmission 
Depression is prevalent in nearly one-third of hospitalized patients, and continues to 
affect half of these patients for at least one month post-discharge (Pederson et al., 2016). 
Depression has been found to not only increase risk for adverse outcomes and increased 
mortality, but also increases risk for readmission in post-MI patients (Hess et al., 2016; 
Szpakowski, Bennell, Qui, Kirdyak, & Wijeysundera, 2016). Risk for readmission has been 
thought to be influenced by how depression often impacts a patient’s functional status, i.e. ability 
to comply with medication regimen, continue follow-up for medical care, and self-care (Hess et 
al., 2016).  
Hess et al. (2016) conducted a study examining readmission within 30 days after 
discharge in post-MI patients. The authors examined multiple factors associated with 30-day 
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readmission, including: demographics, comorbidities, presentation features, procedure features, 
in-patient events, medication use, etc. Results of the study found a 10% 30-day readmission rate 
after discharge post-MI, and that the most strongly associated factors increasing risk for 
readmission were patients who had depression and lower quality of life (Hess et al., 2016).  
Health behaviors and other comorbidities, such as diabetes mellitus, obesity, 
hypertension, hyperlipidemia, etc., in patients with depression post-MI have also been linked to 
the risk for readmission (Myers et al., 2012). Patients with depression post-MI are less likely to 
adhere to newly recommended secondary prevention measures putting them at increased risk for 
readmission (Myers et al., 2012). Secondary prevention methods that the AHA guidelines 
recommend for post-MI patients include the followings: medication therapy, discontinuation of 
tobacco use, encouragement of physical activity, attendance to a cardiac rehabilitation program, 
healthy diet, and management of other comorbidities (O’Gara et al., 2013).  
A study examining medication adherence post-MI found that depressed patients are 
directly associated with non-adherence to their medication regimen, and recommend methods to 
improve adherence (Gehi, Haas, Pipkin, & Whooley, 2005). Depressed patients are also unlikely 
to follow physical activity recommendations post-MI (Whooley et al., 2008). Therefore, 
strategies, such as depression screening, in conjunction with other secondary prevention 
measures, may be beneficial in reducing readmission risk (Hess et al., 2016). 
Theoretical Framework and Logic Model 
The theoretical framework for this project is based on two nursing theories. Betty 
Neuman’s Systems Model theory was found to be applicable to the project based on its concepts 
of holistic nursing care and prevention. The second nursing theory, Hildegard Peplau’s Nurse-
Patient Relationship Theory, emphasizes the importance of the nurse-patient relationship in 
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nursing care, specifically psychiatric care. A logic model has been developed to help guide the 
process of the project by incorporating the planning, implementation, and evaluation phases of 
the project.  
Neuman’s Systems Model 
Neuman’s Systems Model has a holistic view of the patient who is represented by an 
open system that interacts with stressors to achieve a goal of total wellness. Nursing care in this 
theory focuses on the nursing intervention of prevention care.  She believes environmental 
stressors interrupt the balance of the system that could potentially be prevented with early 
intervention. Neuman believed that health and wellness is a dynamic continuum, and the system 
works to achieve stability or wellness on this continuum. Neuman’s conceptual model provides 
visual guidance in application of the four domains of nursing: the human being, environment, 
health, and nursing (Neuman, 1995). 
Neuman developed a conceptual model (Figure 1) called the client-client model 
consisting of five different variables that co-exist within the system: physiological, 
psychological, sociocultural, developmental and spiritual. The core of the model, or basic 
structure, consists of factors common to all humans, such as: normal temperature, genetic 
structure, response pattern, organ strength/weakness, ego structure, and knowns or 
commonalities (Neuman, 1995). The system’s defenses to maintain stability are described in the 
theory as: the lines of resistance, the normal line of defense, and the flexible line of defense. 
Defense mechanisms help the person to adapt and respond to stressors from the external and 
internal environments (Neuman, 1995). 
The use of primary, secondary, and tertiary prevention as a nursing intervention is a key 
concept of nursing care in Neuman’s model. Primary prevention by acting before a stressor 
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occurs strengthens the flexible line of defense, and protects a client’s normal line of defense. 
Secondary prevention is required to treat symptoms from a stressor, and maintain client wellness. 
Lastly, tertiary prevention allows for adaptation to a stressor, prevention of a reoccurrence, 
and/or maintenance of a state of wellness (Neuman, 1995). 
Applications of Neuman’s Systems Model 
Application of Neuman’s Systems Model to this project primarily focuses on her 
concepts of holistic nursing care through collaboration between the nurse and client, and the use 
of prevention as a primary nursing intervention. Post-MI patients physiologically must heal to 
return to a state of wellness, but may also need psychological healing to attain total wellness. The 
model has helped to guide what stressors could be examined in this project that may affect the 
outcomes of depressed post-MI patients, i.e. age, sex, race, screening for depression, diagnosis of 
depression, treatment of depression, etc. In identifying what potential stressors are affecting 
readmission rates of depressed post-MI patients, potential recommendations may be made for 
primary, secondary or tertiary prevention measures in this cohort. Nursing care has the potential 
to improve depressed post-MI patient outcomes through prevention, early identification and 
treatment, and helping patients to cope and adapt to achieve their individual state of wellness. 
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Figure 1. Neuman’s Systems Model. 
Adapted from Betty Neuman (1995) 
Peplau’s Theory of Interpersonal Relations 
Hildegard Peplau’s Theory of Interpersonal Relations emphasizes the nurse-patient 
relationship as being central to all nursing care. The theory may be applied to any nursing 
situation (Peplau, 1992). The nurse brings forth their professional experience and knowledge to 
the relationship with a focus on the needs of the patient (Peplau, 1992).  
The four main factors of the nurse-patient relationship are the nurse, the patient, 
professional expertise, and patient need. Peplau’s theory recognizes that there are phases that the 
relationship will work through starting with the orientation phase. The orientation phase begins 
as the relationship develops, and the nurse and patient begin to understand each other. During 
this phase, trust will begin to be made between the two individuals. The second phase is the 
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working phase in which the patient begins to take part in their care with the nurse guiding them 
when needed. The nurse empowers the patient as the patient becomes more independent in their 
own care. Lastly, the resolution phase occurs as the patient continues to move into a more 
independent role in managing their care as they move away from the nurse. A mutual ending of 
the nurse-patient relationship is the complete end to this final phase as the patient gains 
independence (Peplau, 1992). 
Application of Peplau’s Theory of Interpersonal Relations 
Peplau’s Theory of Interpersonal Relations applies to the project, because a collaborative, 
trusting relationship between the patient and nurse, or provider, is important in mental health 
care. Depression screening is dependent on the patient being honest in their answers, and in their 
willingness to receive mental health care. A patient who is depressed is more likely to share their 
feelings and concerns to a provider who they trust and have a relationship with. Primary care 
providers are more likely to build a relationship with their patient over time, and patients may 
respond more honestly in screenings when they have a health need. Therefore, The Theory of 
Interpersonal Relations can be incorporated when caring for post-MI patients to ensure that 
patients’ mental health needs are recognized and addressed. 
Logic Model 
The logic model was used to identify main concepts of the project including: inputs, 
activities, outputs, and outcomes. In the planning phase of the model, the inputs and the activities 
were identified to help recognize what resources would be needed, and what steps needed to be 
taken to conduct the project. Implementation of the project included the data collection process, 
data analysis, and dissemination of findings. The next phase of the model determined the outputs 
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expected from the data collected and analyzed. In the final phase of the model, the predicted 
outcomes were identified, and helped to develop the objectives of the project. 
 
Figure 2. Logic Model. 
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Conclusion 
Chapter two focused on a review of the literature, and presented the theoretical 
framework of the project. The literature review examined depression in post-MI patients, 
prevalence and mortality, management of depression post-MI, depression screening 
recommendations, screening tools, barriers to depression screening in post-MI patients, and 
lastly, depression post-MI and readmission’s. Neuman’s Systems Model and Peplau’s Theory of 
Interpersonal Relations were summarized and a discussion was made in relation to the project. 
The information attained in chapter two facilitated the development of the project design, 
implementation of the data analysis, and evaluation of the data analysis which will be discussed 
and reviewed in the next chapter. 
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CHAPTER 3: PROJECT DESIGN  
The study was a quantitative retrospective data analysis performed by examination of 
data from electronic medical records (EMRs). The purpose of the study was to identify rates of 
depression screening post-MI, and determine how it relates to readmission rates within the 
MHO. The study also aimed to determine if other factors contributed to readmission rates post-
MI. The data were obtained with assistance from an information technology (IT) specialist who 
retrieved the necessary data from the EMRs within the MHO. 
To gain access to the data from the EMRs the project proposal was presented to a 
committee of individuals from Region 1 of the MHO who are part of the research, quality 
improvement, and/or student experience departments within the organization. At this meeting, 
the members agreed that the proposed project would be of value to the organization, and granted 
permission for the project to proceed at the MHO. The committee also assigned a liaison at that 
time to help facilitate the project within the MHO.  
Next, obtaining IRB approval from both the MHO IRB and North Dakota State 
University (NDSU) IRB was completed after submitting the required paperwork and research 
proposal. After permission was obtained from the MHO IRB and NDSU IRB, a request for the 
data reports was submitted to the MHO research department. A list of ICD-9 and ICD-10 codes, 
and a table of variables were also submitted with the data request form.  
The ICD-9 and ICD-10 codes requested consisted of MI and depression codes to ensure 
inclusion of all types of MI and depression diagnoses (See Appendix C & Appendix D for ICD 
codes included). A list of variables was also requested to be retrieved from EMRs that met 
inclusion requirements for the study, including: medical record number (MRN), date of birth, 
gender, race, region, if they were deceased, deceased date, admission date with MI diagnosis, 
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readmission’s post MI diagnosis with subsequent MI, depression diagnosis within 12 months 
post-MI, PHQ-9 depression screening conducted within 12 months post-MI, the screening 
provider, and specialty of screening provider. Once the reports were obtained, they were shared 
with an NDSU statistician who assisted in analyzing the data in the reports. 
Sample 
The data sample consisted of men and women ages 40-70 years old who had a diagnosis 
of depression, had experienced an MI, and had visited their primary care provider within 12 
months post-MI. Exclusion criteria included ICD coded diagnoses of other mental health 
disorders (bipolar disorder, schizophrenia, post-traumatic stress disorder, anxiety, etc.) and 
coronary artery bypass graft patients. The data were gathered from a date range of January 1st, 
2012 to December 31st, 2016 to include a five-year representation of data. The data were 
obtained from two different midwestern regions of the healthcare organization to compare 
differences and similarities between the regions. 
EMR Data 
ICD codes were used to retrieve the data from the EMR, and then compiled into two 
separate reports based on region. To include sample data from years 2012-2016 both ICD-9 and 
ICD-10 codes were required to retrieve the requested data. ICD-10 codes replaced ICD-9 codes 
in 2015. Other data variables, such as, demographics, PHQ-9 score, provider performing the 
PHQ-9, and specialty of provider performing the PHQ-9 were retrieved by the IT specialist after 
identifying which patients met sample criteria in the reports. The PHQ-9 screening data were 
retrieved instead of a current procedural terminology (CPT) code for depression screening to 
obtain more data meeting sample criteria. According to the IT specialist, providers at the MHO 
were more likely to input the PHQ-9 depression screening tool than input the CPT depression 
 25 
screening code. Data regarding treatment method, and if a patient was being treated for their 
depression were not obtainable by the IT specialist. For this information to be obtained 
individual charts and clinical notes would have had to have been examined to determine if a 
patient was on antidepressant treatment, receiving therapy, consulted to see psychology, etc. 
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CHAPTER 4: RESULTS 
The data reports received from the MHO included 1,181 patients who had been 
diagnosed with depression within 12 months of their initial MI during the time frame of January 
1st, 2012 to December 31st, 2016. Of the 1,181 patients from both regions, 593 met all inclusion 
sample criteria of the study. Therefore, the sample size of the study was 593. Of these patients, 
348 were of Region 1’s data set, and 245 were of Region 2’s data set.  
The first objective of the study was, “Identify the percentage of readmission in patients 
within 12 months post-MI who have depression”. Of the 593 patients with depression post-MI 
16.52% were readmitted within 12 months post-MI (See Table 1). In examination of the two 
different regions’ readmission rates within 12 months post-MI, Region 1 had 61 readmissions 
(17.53%), and Region 2 had 37 readmissions (15.10%) (See Table 2 and Table 3). 
 
Table 1 
Total Patients Readmitted within 12 Months Post-MI 
N Obs Variable N Mean Std Dev Minimum Maximum 
98 Age 
Days To Readmission 
Days To Deceased 
98 
98 
27 
59 
88 
392 
8 
101 
310 
40 
0 
12 
70 
340 
1105 
 
Table 2 
Regional Total Readmissions within 12 Months Post-MI 
Region N Obs Variable N Mean Std Dev Minimum Maximum 
1 61 Age 
Days To Readmit 
Days To Deceased 
61 
61 
17 
59 
116 
389 
8 
111 
284 
42 
5 
37 
70 
340 
1105 
2 37 Age 
Days To Readmit 
Days To Deceased 
37 
37 
10 
58 
41 
398 
9 
59 
366 
40 
0 
12 
70 
236 
1018 
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Table 3 
Readmission within 12 Months Post-MI by Region 
 Region 1 Region 2 
Readmit Category Frequency Percent Frequency Percent 
Not readmitted 271 77.87 197 80.41 
Readmitted within 12-months 61 17.53 37 15.10 
Readmitted after 12-months 16 4.60 11 4.49 
 
To further examine readmissions overall and regionally, the distribution of days to 
readmission was identified. As seen in Figure 3, the overall distribution of days to readmission 
within 12 months was skewed right with greater than 60% of overall readmissions less than 50 
days post-discharge. In examining the two regions’ distributions of days to readmission within 
12 months, Region 2 had a higher proportion of readmissions within 0-50 days post-discharge 
than Region 1. Region 1’s distribution of days was skewed right, however, it had more 
readmissions than Region 2 past 50 days post-discharge (See Figure 4). 
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Figure 3. Overall Distribution of Days to Readmission. 
 
 
Figure 4. Distribution of Days to Readmission by Region. 
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A timeline of 0-30 days and 31+ days post discharge was also developed (See Table 4). 
Readmissions within 30 days post-discharge are of importance to organizations as this effects 
reimbursement from CMS. Region 1 had 22 of 98 (22.45%) readmissions within 12 months be 
readmitted within 30 days post-discharge. Region 2 had a higher percentage of readmissions 
within 30 days; 27 of the 98 (27.55%) patients readmitted within 12 months in Region 2 were 
readmitted within 30 days post-discharge. 
 
Table 4 
Region 1 Distribution of Days to Readmission 
 Region 1 Region 2 
Readmit Category Frequency Percent Frequency Percent 
0 - 30 Days 22 36.07 27 72.67 
31+ Days 39 63.93 10 27.03 
 
The second objective of the study was to, “Determine the percentage of readmission in 
patients within 12 months post-MI who have depression and were screened for depression”. For 
Region 1, 44.26% of the patients in the sample were not screened for depression within 12 
months post-MI and were readmitted within 1 year compared to 55.74% who were screened, and 
subsequently readmitted within 12 months (See Table 5). In further breaking down the timeline 
to examine 0-30 days and 31+ days post-discharge, of the patients in Region 1 who were 
screened within 12 months post-MI 38.24% were readmitted within 30 days post-discharge. 
Lastly, of the patients who were not screened for depression with 12 months post-MI, 33.33% 
were subsequently readmitted within 30 days post-discharge (See Table 6). Using the Chi-Square 
Test of Independence, the P-value of 0.6921 suggests that there is not a relationship between 
depression screening and readmission within 12 months post-MI for Region 1 (See Table 7). 
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Table 5 
Region 1 Readmissions Relating to Screened or Not Screened within 1 year Post-MI 
Category Frequency Percent 
Not screened within 1 year post-MI 27 44.26 
Screened within 1 year post-MI 34 55.74 
 
Table 6  
Region 1 Readmissions Relating to Screening within 30 days 
Screening Readmit Category 
Frequency 
Expected 
Row Percentage 0 - 30 Days 31+ Days Total 
Not screened within 1 year post-MI 9 
9.7377 
33.33 
18 
17.262 
66.67 
27 
 
 
Screened within 1 year post-MI 13 
12.262 
38.24 
21 
21.738 
61.76 
34 
 
 
Total 22 39 61 
 
Table 7 
Region 1 Chi-Square Test of Independence for Screening and Readmission 
Statistic DF Value Prob 
Chi-Square 1 0.1568 0.6921 
Likelihood Ratio Chi-Square 1 0.1573 0.6917 
Continuity Adj. Chi-Square 1 0.0163 0.8985 
Mantel-Haenszel Chi-Square 1 0.1543 0.6945 
Phi Coefficient  -0.0507  
Contingency Coefficient  0.0506  
Cramer's V  -0.0507  
For the Chi-Square Test of Independence an α=0.05 was utilized. 
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In Region 2, 43.24% of the patients were screened for depression within 12 months, and 
subsequently were readmitted to the hospital. The analysis found that 56.76% of the sample who 
were not screened for depression within 12 months were readmitted (See Table 8). In examining 
the readmission timeline of 0-30 days post-discharge, 81.25% of the sample of patients who were 
screened in Region 2 were readmitted within 30 days post-MI. Lastly, 66.67% of the sample who 
were not screened for depression within 12 months were readmitted within 30 days. (See Table 
9).  
In performing data analysis of Region 2’s data, the Chi Square Test of Independence 
resulted in a P-value of 0.3224, however since the contingency table included expected counts 
less than 5, the Fisher’s Exact Test was indicated for a valid test (See Table 10 and Table 11). 
The Fisher’s Exact Test resulted in a P-value of 0.4613 compared to the α-value of 0.05 
suggesting that there is not a relationship between depression screening and readmission within 
12 months post-MI for Region 2 (See Table 11). 
 
Table 8 
Region 2 Readmissions Relating to Screened or Not Screened within 1 year Post-MI 
Screening Frequency % Cumulative Frequency Cumulative % 
Not screened within 1 year post-MI 21 56.76 21 56.76 
Screened within 1 year post-MI 16 43.24 37 100.00 
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Table 9 
Region 2 Readmissions Relating to Screening within 30 days 
Screening Readmit Category 
Frequency 
Expected 
Row Percentage 0 - 30 Days 31+ Days Total 
Not screened within 1 year post-MI 14 
15.324 
66.67 
7 
5.6757 
33.33 
21 
 
 
Screened within 1 year post-MI 13 
11.676 
81.25 
3 
4.3243 
18.75 
16 
 
 
Total 27 10 37 
 
Table 10 
Region 2 Chi-Square Test of Independence for Screening and Readmission 
Statistic DF Value Prob 
Chi-Square 1 0.9792 0.3224 
Likelihood Ratio Chi-Square 1 1.0050 0.3161 
Continuity Adj. Chi-Square 1 0.3794 0.5379 
Mantel-Haenszel Chi-Square 1 0.9528 0.3290 
Phi Coefficient  -0.1627  
Contingency Coefficient  0.1606  
Cramer's V  -0.1627  
For the Chi-Square Test of Independence α=0.05 was utilized. 
Table 11 
Region 2 Fisher’s Exact Test 
Fisher's Exact Test 
Cell (1,1) Frequency (F) 14 
Left-sided Pr <= F 0.2716 
Right-sided Pr >= F 0.9154 
Table Probability (P) 0.1869 
Two-sided Pr <= P 0.4613 
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The third objective of the study was, “Determine the percentage of readmission in 
patients within 12 months post-MI who have depression, were screened for depression, and 
treated for depression”. To complete this objective, treatment data would have been necessary to 
obtain. The IT specialist of the MHO was unable to retrieve treatment data as this would have 
required individual examination of charts and clinic notes. Therefore, this objective was unable 
to be completed, but will be further discussed in the next Chapter. 
The fourth objective of the study was, “Identify correlations or differences that can be 
made for depressed post-MI patients and demographic variables”. Demographics between the 
two regions of the sample had similarities and differences. The age range of the sample was kept 
to 40-70-year-old patients with the age representing the patient’s age as of the first MI admission 
date. The overall distribution of age among the entire sample had a skewed-left distribution with 
a mean age of 58 years old (See Figure 5). The two regions had similar mean ages with Region 1 
having a mean age of 59 years old and Region 2 having a mean age of 58 years old. However, 
Region 2 had a much higher proportion of their population at age 56 years old compared to 
Region 1 (See Figure 6). 
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Figure 5. Overall Distribution of Age. 
 
 
Figure 6. Distribution of Age by Region. 
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In examining the gender of the regions, both regions had higher frequencies of males than 
females. Region 1 sample consisted of 175 males (50.29%) and 173 females (49.71%). Region 2 
sample consisted of 130 males (53.06%) and 115 females (46.94%) (See Table 12).  
While examining the race of the sample, Caucasian/White had the highest frequency for 
both regions. Region 1 consisted of 92.24% Caucasian/White patients, 4.31% American 
Indian/Alaskan Native patients, 0.57% African American/Black patients, 0.57% Asian patients, 
and 2.30% that declined to identify race in their chart. Region 2 consisted of 89.80% 
Caucasian/White patients, 6.12% American Indian/Alaskan Native patients, 1.22% African 
American/Black patients, 1.63% Asian patients, 0.41% Hispanic/Latino patients, and 0.82% that 
declined to identify race in their chart (See Table 13). 
 
Table 12 
Gender by Region 
 Region 1 Region 2 
Gender Frequency Percent Frequency Percent 
Female 173 49.71 115 46.94 
Male 175 50.29 130 53.06 
 
Table 13 
Race by Region 
 Region 1 Region 2 
Race Frequency Percent Frequency Percent 
African American/Black 2 0.57 3 1.22 
American Indian or Alaskan Native 15 4.31 15 6.12 
Asian 2 0.57 4 1.63 
Caucasian/White 321 92.24 220 89.80 
Hispanic/Latino n.a. n.a. 1 0.41 
Declined 8 2.30 2 0.82 
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Objective five of the study was, “Determine what type of provider screened, diagnosed, 
and/or treated for depression in the sample”. The type of provider performing the PHQ-9 screen 
was provided when able to for individual patients, however, many patients screened had an 
unknown healthcare professional listed as the screener. For region 1, 271 of the 348 patients had 
an unknown provider listed. For region 2, 201 of the 245 patients had an unknown provider listed 
(See Table 14). The data provided by the MHO also did not include the type of provider 
diagnosing depression or the type of provider treating depression as this would have required 
individual examination of charts and clinic notes. 
 
Table 14 
Provider Type Performing Depression Screen- Region 1 and Region 2 
 Region 1 Region 2 
Specialty Frequency Percent Frequency Percent 
Clinical Nurse Specialist 6 1.72 n.a. n.a. 
Medical Doctor 54 15.52 34 13.88 
Nurse Practitioner 6 1.72 5 2.04 
Physician's Assistant 9 2.59 5 2.04 
Social Worker 2 0.57 n.a. n.a. 
Unknown 271 77.87 201 82.04 
 
Conclusion 
Chapter Four provided an overview of the results of the data collection and data analysis 
in relation to the objectives developed for the study. Chapter Five provides identification and 
interpretation of the results and outputs for the objectives of the study. The next chapter also 
discusses limitations, recommendations for future research, and implications for advanced 
nursing practice. 
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CHAPTER 5: DISCUSSION AND RECOMMENDATIONS 
In this retrospective data analysis, there were no statistically significant relationships 
found between depression screening in post-MI patients and readmission within 12 months. 
Despite these findings, numerous guidelines continue to recommend screening, and studies 
continue to find that systematic depression screening post-MI is associated with improved health 
outcomes. Many of the findings in this analysis are consistent with findings of past studies, and 
will be further discussed in this chapter.  
Interpretation of Results 
Objective One 
The first objective of the study, “Identify the percentage of readmission in patients within 
12 months post-MI who have depression”, was completed with data outputs that were difficult to 
compare to past research findings. As stated in the results section, the overall readmission rate 
within 12 months post-MI for patients with depression was 16.52%. In looking at 30-day 
readmission rates of the 98 patients readmitted within 12 months post-MI, Region 1 had a 
22.45% readmission rate and Region 2 had a 27.55% readmission rate. In performing the 
literature review, few studies examined readmission rates with a similar cohort to make 
comparisons of this study’s findings. However, a study conducted by Hess et al. (2016), 
examined post-MI patients and 30-day readmission rates, and found that 10.8% of the 12,312 
patients examined were readmitted in 30-days with one of the highest risks for readmission being 
depression. Another study examined 30-day readmissions for acute MI’s and found a 21.7% 
readmission rate for patients with psychiatric comorbidities (Ahmedani et al., 2015). 
 This study demonstrated that the overall readmission rate within 12 months post-MI is 
similar to these past research findings, however, in looking at the individual regions’ 30-day 
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readmission rates the researchers found they had slightly higher rates for readmission compared 
to other 30-day readmission studies. This may be because the patients in study are at higher risk 
for readmission by having a psychiatric comorbidity of depression as suggested by past studies. 
Therefore, it is difficult to determine consistency of readmission rate data findings for this 
analysis to past research without having more comparison studies examining the population of 
depressed post-MI patients. 
Objective Two 
The second objective of the study, “Determine the percentage of readmission in patients 
within 12 months post-MI who have depression and were screened for depression” was met. In 
comparing the two regions, it was interesting to find that Region 1 had higher readmission rates 
in patients who were screened for depression compared to patients who were not screened 
(55.74% vs. 44.26%), and Region 2 had lower readmission rates in patients who were screened 
compared to patients who were not screened (43.24% vs. 56.76%). The differences in screening 
and readmission for the regions is unknown. Both regions utilize the PHQ-2 and PHQ-9 
screening tools, and both utilize cardiac rehabilitation programs. However, it is unknown if the 
regions have different follow-up or treatment protocols for positive screens, or if the cardiac 
rehabilitation programs are conducted differently. The study did not examine any components of 
cardiac rehabilitation, or even if a patient attended a program.  
In performing the statistical analysis of the data for patients screened and readmitted 
within 30 days post-discharge, both regions showed no statistically significant relationship 
between the categories. As suggested by past evidence, the data of this study were expected to 
reflect a relationship for lower readmission rates in patients who were screened and treated for 
depression. However, there are no studies that have been found that specifically examined 
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readmission rates and depression screening post-MI to make exact comparisons. Multiple past 
studies have suggested that routine depression screening post-MI may be effective in decreasing 
readmissions, however, further studies are needed to assess implications of depression screening 
(Bertelsen et al., 2017; Hess et al., 2016; Pederson et al., 2016). Although screening for 
depression post-MI is recommended in many studies and reputable guidelines, the most 
important aspect is following up on a positive screen and treating patients if appropriate. An 
important missing factor of the data in this study included if the patients were screened, and then 
treated for their depression. As discussed in the next section, treatment is key to improved 
depression symptoms and post-MI health outcomes.  
Objective Three 
The third objective, “Determine the percentage of readmission in patients within 12 
months post-MI who have depression, were screened for depression, and treated for depression”, 
was unable to be completed. As stated in the results section, treatment data for depression of the 
sample was unable to be retrieved by IT of the MHO for this study. Unfortunately, the resources 
and time needed to perform that type of analysis was not available. In the development of the 
objectives for the study it was thought that treatment data would be attainable, however, to 
examine treatment data for the sample thorough investigation of individual patient charts and 
clinical notes would have been necessary. That process would require a team of qualified 
investigators as well as significant economic and human resources. 
As current guidelines recommend, depression screening should routinely be performed in 
post-MI patients to identify patients who may be depressed, and then provide adequate treatment 
for their symptoms (Green et al., 2009; Lichtman et al., 2008). Post-MI patients with depression 
who receive treatment are found to have better health outcomes, improved medication adherence, 
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and decreased mortality (Glassman et al., 2002; Siu & USPSTF, 2016; Zuidersma et al., 2013). 
An important consideration in treating post-MI patients with depression includes monitoring 
effectiveness of treatment. A recent study examined treatment resistant depression in post-MI 
patients and found that 13.4% of the sample had treatment resistant depression requiring patients 
to trial multiple medication options before achieving improvement in depressive symptoms. The 
authors concluded that effective treatment and monitoring of depression shows reduced mortality 
and improved cardiac outcomes in post-MI patients (Banankhah et al., 2015). Currently there is a 
gap in the literature regarding depression screening and treatment in post-MI patients, and the 
implications on readmissions to the hospital. A statistical analysis examining the relationship 
among screening for depression, treating depression, and readmission rates post-MI would have 
been interesting to learn. Unfortunately, treatment data were not able to be examined for this 
study, therefore future research and studies would be of value to provide evidence of the impact 
treating depression in post-MI patients has on readmission rates. 
Objective Four 
The fourth objective “Identify correlations or differences that can be made for depressed 
post-MI patients and demographic variables” was met. Many consistent findings were found that 
were similar to past research. Age, gender, and race were examined for this study, but many 
other demographic considerations such as socioeconomic status, education level, or marital 
status. would be interesting for future studies focusing on demographic variables of the cohort. 
As discussed earlier, the sample age range of 40-70 years old was chosen to include 
patients of similar expected health and to exclude younger, generally healthy patients, and older, 
generally more frail patients. Many studies examining depression post-MI utilized similar sample 
age ranges, or sample ages of greater than or equal to 18 years old. The mean age of patients for 
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Region 1 and Region 2 for this study were 59 and 58 years old, respectively. These findings are 
consistent with past research findings with a majority of studies examining depression post-MI 
finding mean sample ages of 56-65 years old (Edmondson et al., 2014; Hess et al., 2017; 
Southern, 2014). This author concludes that patients within this age range are at higher risk for 
readmission post-MI, and thus, practitioners should be screening these patients for depression to 
reduce risk of readmission. 
An unexpected finding of the data was that samples for both regions consisted of more 
males than females. Previous studies that included examination of gender found that females are 
more likely to experience depression post-MI and experience adverse outcomes (Hess et al., 
2017; Smolderen et al., 2017). In fact, studies have even found that females were more likely to 
be readmitted post-MI compared to males (Dreyer et al., 2015; Parashar et al., 2009). Depression 
in the general adult population is also more prevalent in females by 3.7% (National Institute of 
Mental Health [NIMH], 2016). Determining why the male gender had a higher frequency in the 
data of this study is difficult to explain. Females have longer life expectancies than males, and 
possibly if the age range had been expanded to include older patients in the sample it would 
reflect a higher frequency of females readmitted with depression post-MI (National Center for 
Health Statistics, 2017).  
In examining the racial differences of the study sample, Caucasian/White patients were 
the highest frequency followed by American Indian/Alaskan Native patients as the second 
highest frequency in both regions. This demographic finding was expected, as this coincides with 
the state population data for both regions. The states in which the regions belong have by far a 
higher population of Caucasian/White persons compared to any other race, which is followed by 
the second highest population of American Indian/Alaskan Natives (Unites States Census 
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Bureau, 2016). However, another study examining racial and sex differences in post-MI patients 
with unplanned readmissions found that the highest risk patients for readmission were African 
American females, followed by White females, African Americans males, and lastly White 
males (Hess et al., 2017). A limitation of this study is that the researchers only compared White 
versus African American race groups and excluded any other races. For the regions included in 
this author’s study, the population of African Americans was low compared to other regions in 
the United States. Despite previous evidence, finding African Americans as the highest 
frequency race was not an expected finding in this study sample. However, further research and 
studies examining age, gender, and racial disparities among depressed post-MI patients in the 
two regions examined and in other regions of the U.S. would be interesting to identify further 
correlations and risks for readmission. 
Objective Five 
Objective five “Determine what type of provider screened, diagnosed, and/or treated for 
depression in the sample” was partially met as the data findings were largely inconsistent. The 
data that were retrieved from IT was pulled from input boxes in the chart that record which 
provider is charting. For both regions an unknown category performed the majority of depression 
screening followed by the category of medical doctor (See Table 18 and Table 19). The unknown 
category is predicted to be made up of nursing staff who often perform and input the depression 
screen into charts as part of the rooming process in the clinic setting. Unfortunately, IT was also 
unable to pull data identifying who made the diagnosis or treatment for patients in the sample. 
Further investigation via actual physical review of individual charts and clinical notes would be 
required to obtain all the data to meet this objective. Also, improvements of the EMR, or in the 
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data retrieval process, could be made to more easily identify who made up the unknown category 
in the flowsheets. 
Additional Discussion: Deceased Rates 
Much of past literature has examined the impact that depression has on mortality rates 
post-MI. Although examining mortality and/or deceased rates were not objectives of the study, 
the deceased rates were gathered along with the other data. Of the 593 patients who made up the 
sample for this analysis, 117 (19.7%) were deceased at the time of the analysis. In comparing the 
two regions, Region 1 had 10.63% of the 348 patients in the sample were deceased within 12 
months post-MI, and Region 2 had 8.98% of the 245 patients in the sample were deceased within 
12 months post-MI. In Figure 7, a side by side comparison is given for the regions with both 
showing a higher percentage of deaths were under 60 days post-MI. Further research should be 
conducted on the data found to examine mortality and death rates for this cohort. A recent 
finding of researchers examining depression and the risk of death following coronary artery 
diagnosis, concluded that depression following a cardiovascular event was the strongest predictor 
of death (May et al., 2017). In another recent study, reserachers found that long-term mortality 
risks are elevated in depressed post-MI patients, but more so in patients who have untreated 
depression (Smolderen et al., 2017). Therefore, identification, treatment, and follow-up for 
depressed post-MI patients is of utmost importance to decrease risk of mortality.  
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Figure 7. Distribution of Days to Deceased in 12 Months by Region. 
 
Limitations 
Research limitations included the inability to obtain all data, potential missing data, 
potential inapplicability of findings to other regions, and unknown past depression history of 
patients. As discussed prior, one limitation of the study was the inability to obtain all requested 
data. The data that was collected from the MHO had been either entered into flowsheets, 
associated with an ICD code, and/or associated with the MRN (admission date, deceased date, 
etc.). Unfortunately, all treatment related data were unable to be obtained as this would have 
required individual investigation of patient charts and provider clinical notes. Although the 
treatment component of the study would have been valuable, going back through individual 
charts to obtain this information was not feasible. 
A second limitation of the data output includes the inability to determine if a PHQ-9 
screening was performed based solely on flowsheet data. A conclusion cannot be made that a 
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provider did not perform a depression screening by examining flowsheet data alone. A provider 
may have charted the screening results within their clinical notes, or they may have not recorded 
it at all despite having asked the appropriate questions from the PHQ-2 or PHQ-9. With PHQ-9 
screening data pulled only from flowsheets there is the potential that data may have been missed. 
Another consideration for missing PHQ data, is that the EMR the MHO utilizes has a file button 
that must be pushed to submit the results; if not pushed, the result will not be recorded. In 
conclusion, appropriate charting and recording of PHQ results is needed to provide accurate and 
consistent assessment data within the organization. 
A third limitation of the study is that the data were obtained from a mid-western region in 
the U.S., and the data analysis may not be applicable to other regions. The Midwest has a higher 
proportion of Caucasian/white population with a low population of African Americans, 
Hispanic/Latinos, or Asians compared to other regions (United States Census Bureau, 2016). 
African Americans, Hispanic/Latinos, and Caucasians have the highest risk for cardiovascular 
disease compared to other races (Centers for Disease Control & Prevention, 2013). American 
Indians/Alaskan Natives and Caucasians have the highest prevalence of adult depression in the 
U.S. (NIMH, 2016). Therefore, data findings examining race in depressed post-MI patients in 
other regions may have different results. More studies and investigations are needed to make any 
recommendations. 
Lastly, a fourth limitation is that past depression history of the individual patients in the 
sample was unknown, and was not taken into consideration for the purpose of this study. The 
study did not assess if a patient had a history beyond one year prior to admission. This is 
important to acknowledge as patients with a past history of depression (recurrent or chronic) 
should be continually assessed for depressive symptoms, for worsening symptoms, and/or have 
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continual treatment follow-up. Patients with a history of depression are at risk for recurrent 
depression especially with a major life event, such as a MI. As this author has discussed, 
depression post-MI increases risk for adverse outcomes. In fact, a study by Sundboll et al. 
(2017), found that a history of depression post-MI was associated with increased all-cause 
mortality. 
Recommendations 
The first recommendation that can be made for these regions of the MHO is the 
development of a protocol or quality measure to ensure post-MI patients are screened for 
depression and results documented at follow-up visits. Although this data analysis did not find a 
relationship between depression screening and readmissions to the hospital, past evidence and 
current guidelines emphasize the importance of identifying depression post-MI. Once a 
depression screen is positive, a clinical interview by the provider is needed to accurately 
diagnosis depression to avoid any false-positive screenings. Once a depression diagnosis is 
established, ensuring patients receive appropriate treatment for depression post-MI has been 
shown to decrease risks for mortality and adverse outcomes in numerous studies (Glassman et 
al., 2002; Siu & USPSTF, 2016; Zuidersma et al., 2013). 
A second recommendation for the regions of the MHO is to ensure the PHQ-2 or the 
PHQ-9 screening results are recorded in the chart appropriately to maintain consistency within 
the organization. The data analysis used for this study was unable to investigate individual charts 
or clinical notes; however, potential depression screening information may be found in other 
locations other than the flowsheet. Also, providers and other staff may be missing the file submit 
button and mistakenly not recording PHQ results. Therefore, accurate use of the flowsheet and 
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use of another mechanism would allow for consistent charting, and assessment of past screening 
results within the MHO. 
A final recommendation can be made for the development and implementation of further 
studies and practice improvement projects relating to depression in post-MI patients. The author 
of this study found a gap in the literature regarding examination of readmission rates in 
depressed post-MI patients. Addressing risks for readmission are of importance to any 
organization with our current and future healthcare state providing financial incentives 
emphasizing quality of care and health outcomes.  
Future analysis of depression screening, depression treatment and effect on readmissions 
post-MI would be valuable in providing insight to the relationship between these variables, and 
provide evidence for improved depression healthcare. It should be noted that a study examining 
depression treatment post-MI and its relationship to readmissions would require a cross-sectional 
and a longitudinal methodology to collect data and investigate individual treatment options 
provided to patients. Lastly, a future study would benefit from a team approach with improved 
IT support to retrieve data and provide access to charts, and assistance from other researchers in 
examining individual patient charts and clinical notes to ensure all screening and treatment data 
is collected. 
Implications for Advanced Nursing Practice 
Ongoing efforts must continue to be made to improve depression and mental healthcare 
for post-MI patients. The AHA and the AAFP recognize the importance of providers to identify 
depressive symptoms in post-MI patients to ensure appropriate treatment and follow-up is 
provided. Advanced practice registered nurses (APRNs) must stay current with and utilize 
evidence-based recommendations to guide patient care and decision making. Currently the 
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AAFP is in the process of updating their guidelines regarding depression screening and treatment 
in post-MI patients. In reviewing the Journal of the American Academy of Nurse Practitioners, 
The Journal for Nurse Practitioners, and The National Organization of Nurse Practitioner 
Faculties, no relevant data pertaining to depression in cardiac patients was found, and confirms 
the need for additional studies to be completed and published in nurse practitioner related 
journals. As more studies and analyses are conducted regarding this topic it will be interesting to 
learn of any new recommendations that can be made for improved practices. 
APRNs are uniquely prepared through their education and training to meet the challenges 
and complexity of our healthcare system. They have the opportunity to improve cost-savings 
within their organization. When APRNs are involved on collaborative teams, the holistic 
approach and strengths they bring have shown to decrease 30-day readmission rates by 50%, 
improve overall patient outcomes, and effectively reduce costs (David, Britting, & Dalton, 2015; 
Kutzleb et al., 2015). Integration of APRNs into inpatient or outpatient settings would be of 
benefit to any organization. 
Lastly, findings from this study can be used to increase awareness among APRNs and 
other providers of the risks for readmission in post-MI patients with depression. The implications 
of the study are to ensure that depression screening is performed and documented, and that 
depressed patients receive appropriate treatment and depression care. APRNs have the 
opportunity to conduct further studies on this topic to further investigate risks for readmission 
and identify any other implications for practice improvement. APRNs should also implement 
quality improvement measures regarding depression screening and treatment of post-MI patients 
within their own clinical practice to improve depression management, health outcomes for post-
MI patients, and cost-savings to the patient and organization. 
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Conclusion 
This data analysis is one of few known studies that has examined risk for readmission 
and readmission rates in post-MI patients with depression. The retrospective review of MI and 
depression in these regions is the only known review completed by the organization. Overall, a 
statistically significant relationship between depression screening post-MI patients and 
readmission to the hospital in either regions was not found in this study. However, a relationship 
between depression treatment in post-MI patients and readmissions could not be determined due 
to inability to fully retrieve appropriate data. Numerous past findings have suggested improved 
health outcomes and health cost-savings for patients who are treated for depression post-MI. 
Therefore, further research should be conducted to examine the implications treating depression 
has on post-MI readmission rates. In conclusion, depression must be screened for, identified, and 
appropriately treated in post-MI patients to reduce risk of mortality, adverse outcomes, 
readmissions to the hospital, and reduce healthcare costs. 
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APPENDIX C: ICD-9 & ICD-10 CODES FOR ACUTE MYOCARDIAL INFARCTION 
Table C1 
ICD-9 Codes for Acute Myocardial Infarction 
ICD-9 
Code 
Description 
410.00 Acute Myocardial Infarction of Anterolateral Wall, episode of care unspecified 
410.01 Acute Myocardial infarction of Anterolateral Wall, initial episode of care 
410.10 Acute Myocardial Infarction of Other Anterior Wall, episode of care unspecified 
410.11 Acute Myocardial Infarction of Other Anterior Wall, initial episode of care 
410.20 Acute Myocardial Infarction of Inferolateral Wall, episode of care unspecified 
410.21 Acute Myocardial Infarction of Inferolateral Wall, initial episode of care 
410.30 Acute Myocardial Infarction of Inferoposterior Wall, episode of care unspecified 
410.31 Acute Myocardial Infarction of Inferoposterior Wall, initial episode of care 
410.40 Acute Myocardial Infarction of Other Inferior Wall, episode of care unspecified 
410.41 Acute Myocardial Infarction of Other Inferior Wall, initial episode of care 
410.50 Acute Myocardial Infarction of Other Lateral Wall, episode of care unspecified 
410.51 Acute Myocardial Infarction of Other Lateral Wall, initial episode of care 
410.60 True Posterior Wall Infarction, episode of care unspecified 
410.61 True Posterior Wall Infarction, initial episode of care 
410.70 Subendocardial Infarction, episode of care unspecified 
410.71 Subendocardial Infarction, initial episode of care 
410.80 Acute Myocardial Infarction of Other Specified Sites, episode of care unspecified 
410.81 Acute Myocardial Infarction of Other Specified Sites, initial episode of care 
410.90 Acute Myocardial Infarction of Unspecified Site, episode of care unspecified 
410.91 Acute Myocardial Infarction of Unspecified Site, initial episode of care 
 
Table C2 
ICD-10 Codes for Acute Myocardial Infarction 
ICD-10 
Code 
Description 
I21.09 ST Elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall 
I21.11 ST Elevation (STEMI) myocardial infarction involving right coronary artery 
I21.19 ST Elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall 
I21.29 ST Elevation (STEMI) myocardial infarction involving other sites 
I21.3 ST Elevation (STEMI) myocardial infarction of unspecified site 
I21.4 Non-ST elevation (NSTEMI) myocardial infarction 
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APPENDIX D: ICD-9 & ICD-10 CODES FOR DEPRESSION 
Table D1 
ICD-9 Codes for Depression 
ICD 9 
Code 
Description 
296.20 Major Depressive Affective Disorder Single Episode Unspecified Degree 
296.21 Major Depressive Affective Disorder Single Episode Mild Degree 
296.22 Major Depressive Affective Disorder Single Episode Moderate Degree 
296.23 Major Depressive Affective Disorder Single Episode Severe Degree W/o Psychotic Behavior 
296.24 Major Depressive Affective Disorder Single Episode Severe Degree W/ Psychotic Behavior 
296.25 Major Depressive Affective Disorder Single Episode In Partial Or Unspecified Remission 
296.26 Major Depressive Affective Disorder Single Episode In Full Remission 
296.30 Major Depressive Affective Disorder Recurrent Episode Unspecified Degree 
296.32 Major Depressive Affective Disorder Recurrent Episode Mild Degree 
296.32 Major Depressive Affective Disorder Recurrent Episode Moderate Degree 
296.33 Major Depressive Affective Disorder Single Recurrent Severe Degree W/o Psychotic Behavior 
296.34 Major Depressive Affective Disorder Recurrent Episode Severe Degree W/ Psychotic Behavior 
296.35 Major Depressive Affective Disorder Recurrent Episode In Partial Or Unspecified Remission 
296.36 Major Depressive Affective Disorder Recurrent Episode In Full Remission 
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Table D2 
ICD-10 Codes for Depression 
ICD-10 
Code 
Description 
F32 Major depressive disorder, single episode 
F32.0 Major depressive disorder, single episode, mild 
F32.1 Major depressive disorder, single episode, moderate 
F32.2 Major depressive disorder, single episode, severe without psychotic features 
F32.3 Major depressive disorder, single episode, severe with psychotic features 
F32.4 Major depressive disorder, single episode, in partial remission 
F32.5 Major depressive disorder, single episode, in full remission 
F32.8 Other depressive episodes 
F32.9 Major depressive disorder, single episode, unspecified 
F33 Major depressive disorder, recurrent 
F33.0 Major depressive disorder, recurrent, mild 
F33.1 Major depressive disorder, recurrent, moderate 
F33.2 Major depressive disorder, recurrent severe without psychotic features 
F33.3 Major depressive disorder, recurrent severe with psychotic symptoms 
F33.4 Major depressive disorder, recurrent, in remission 
F33.40 Major depressive disorder, recurrent, in remission, unspecified 
F33.41 Major depressive disorder, recurrent, in partial remission 
F33.42 Major depressive disorder, recurrent, in full remission 
F33.8 Other recurrent depressive disorders 
F33.9 Major depressive disorder, recurrent, unspecified 
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APPENDIX E: EXECUTIVE SUMMARY 
Depression is the leading cause of disability world-wide, and cardiovascular disease 
continues to be the deadliest disease world-wide and in the United States. The economic burden 
of depression is estimated at $210.5 billion, and the most significant portion of this burden 
relates to comorbidities with depression. Depression is highly prevalent after a myocardial 
infarction, and occurs in one in every five patients. However, depression often goes 
unrecognized in patients with cardiovascular disease, thus creating an area of concern. 
A data analysis was conducted using past electronic medical record data obtained from 
two regions of a midwestern healthcare organization. The data were analyzed to assess for risk 
factors contributing to readmission to the hospital in post-myocardial infarction patients with 
depression. Depressed patients are at highest risk for readmission within the first year after a 
myocardial infarction (MI), therefore the study examined if depression screening within 12 
months after a myocardial infarction influenced readmission rates.   
Background 
Depression in post-myocardial infarction patients increases risk for adverse outcomes and 
mortality. Studies have found that untreated depression post-myocardial infarction increases risk 
for mortality, readmissions, and further complications. In fact, depression has been found to 
double the risk of death after a heart attack. Lastly, untreated depression had twice as high of a 
mortality rate compared to treated depression 1 year post-myocardial infarction. This last point 
emphasizes the importance of depression screening and treatment in post-MI patients. 
The American Heart Association and American Academy of Family Physicians 
developed guidelines recommending routine depression screening in post-myocardial infarction 
patients. They emphasize the importance of providing appropriate treatment interventions to 
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improve health outcomes in patients who have depression. The data analysis was developed 
based on these guidelines’ recommendations, past research evidence, and after meetings with the 
organization. 
Process 
The data were collected with collaboration of an IT specialist who used diagnosis codes, 
called ICD codes, to retrieve data from patient charts. Components of the analysis included: 
identifying readmission rates in depressed post-myocardial infarction patients, identifying 
readmission rates in depressed post-myocardial infarction patients who were screened for 
depression, and identifying readmission rates in depressed post-myocardial infarction patients 
who were screened and treated for depression. Other data components included age, gender, 
race, death rates, and type of provider performing depression screening. A statistician performed 
the statistical analyses of the results, and then evaluation of the results was conducted. 
Findings and Conclusion 
First, readmission rates were analyzed from the data sets. There was an overall rate of 
16.5% of patients who were readmitted within 12 months post-myocardial infarction. A category 
of readmission within 0-30 days post discharge was developed since readmissions within 30 days 
post-discharge are of importance to organizations as they effect reimbursement from the Centers 
for Medicare & Medicaid Services. Region 1 had a 22.4% 30-day readmission rate, and Region 2 
had a 27.55% 30-day readmission rate. 
Demographic data findings had consistencies and differences when comparing to past 
study findings. The median ages for Region 1 and Region 2 were 58 and 59 years old, 
respectively. This is consistent with past study findings of a median age range of 56-65 years old. 
The study had a higher number of males than females who had depression post-MI. This finding 
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is inconsistent with past findings that females are more commonly found to have depression 
post-MI. Lastly, race of the data sample was examined, and found that the highest number of 
patients were Caucasian followed by the second highest race of American Indians/Alaskan 
Natives. This finding was expected as Caucasians make up the largest portion of the population 
in the Midwest, and have the highest incidence of adult depression in the U.S. 
In performing statistical analysis of these findings, there were no statistically significant 
relationships found between depression screening and readmission post-myocardial infarction for 
either region. Treatment data were unobtainable for this data analysis. A prediction of the study 
was to find a significant relationship between depression screening, treatment, and decreased 
readmission rates. However, no conclusions can be made regarding implications that depression 
treatment has on readmission rates in post-myocardial infarction patients for these regions. 
Recommendations for Further Action 
The first recommendation that can be made for the regions is development of a protocol 
or quality measure to ensure post-myocardial infarction patients are screened for depression and 
appropriately treated at follow-up visits with their primary care provider (Green et al., 2009). 
Screening patients for depression allows for better identification of depressive symptoms post-
myocardial infarction. A second recommendation for the regions is to ensure that the depression 
screening tool results are recorded in the chart appropriately to maintain consistency of 
documentation within the organization. Lastly, a final recommendation can be made for the 
development and implementation of future research and practice improvement projects relating 
to depression in post-MI patients. Future analysis of depression screening, depression treatment, 
and effect on readmissions post-MI would be valuable in providing insight to their relationship, 
and provide evidence for improved depression healthcare. 
